Updated on 11-August-2022 - For a general description of the protein see 5-hydroxytryptamine receptor
{"openlevels":0}
- 5-HT 1A
- 7e2z – hHT1A/ cytochrome b562 (mutant) + guanine nucleotide-binding protein – Cryo EM
- 7e2y – hHT1A/ cytochrome b562 (mutant) + guanine nucleotide-binding protein + serotonin– Cryo EM
- 5-HT 1B
- 4iaq, 4iar, 5v54 – hHT1B/cytochrome b562 (mutant) + drug - human
- 7c61 – hHT1B/cytochrome b562 (mutant) + antibody
- 6g79 – hHT1B + guanine nucleotide-binding protein
- 5-HT 1D
- 7e32 – hHT1D + guanine nucleotide-binding protein + Scfv + serotonin – Cryo EM
- 5-HT 1F
- 7exd – hHT1F + guanine nucleotide-binding protein + Scfv + drug – Cryo EM
- 5-HT 2A
- 6a93, 6a94, 7vod, 7voe, 7wc5, 7wc7, 7wc8, 7wc9 – hHT2A/cytochrome b562 (mutant) + drug
- 7wc4 – hHT2A/cytochrome b562 (mutant) + serotonin
- 7wc6 – hHT2A/cytochrome b562 (mutant) + LSD
- 6wgt – hHT2A/cytochrome b562 + hallucinogen
- 6wh4 – hHT2A/cytochrome b562 + agonist
- 7ran – hHT2A + guanine nucleotide-binding protein + Scfv + agonist – Cryo EM
- 5-HT 2B
- 4nc3 – hHT2B/cytochrome b562 (mutant)
- 4ib4 – hHT2B/cytochrome b562 (mutant) + drug
- 5tvn – hHT2B/cytochrome b562 (mutant) + LSD
- 5tud – hHT2B/cytochrome b562 (mutant) + antibody
- 6drx, 6dry, 6drz, 6ds0 – hHT2B/cytochrome b562 + agonist + cholesterol
- 5-HT 2C
- 6bqg, 6bqh – hHT2C/cytochrome b562 (mutant) + ergotamine
- 5-HT 3A
- 4pir – mHT3A + VHH15 - mouse
- 6be1 – mHT3A – Cryo EM
- 6his – mHT3A + drug
- 6np0, 6w1j, 6w1m, 6w1y, 6y1z – mHT3A + drug – Cryo EM
- 6dg7, 6dg8, 6hin, 6hio, 6hiq – mHT3A + serotonin – Cryo EM
- 6y59, 6y5a, 6y5b – mHT3A (mutant) + serotonin – Cryo EM
- 5-HT 4
- 7xt9, 7xta – hHT4 + guanine nucleotide-binding protein + serotonin – Cryo EM
- 7xt8 – hHT4 + guanine nucleotide-binding protein + nanobody + serotonin – Cryo EM
- 5-HT 5A
- 7um5, 7um6, 7um7 – hHT5A + minigo + guanine nucleotide-binding protein + scFv + drug – Cryo EM
- 7um4 – hHT5A + PGS + quinolone derivative
- 5-HT 6
- 7xtb – hHT6 + guanine nucleotide-binding protein + nanobody + serotonin – Cryo EM
